Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer (2023)
Attributed to:
Cellular plasticity and senescence at the origin of lung cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/1535-7163.mct-22-0643
PubMed Identifier: 36752780
Publication URI: http://europepmc.org/abstract/MED/36752780
Type: Journal Article/Review
Parent Publication: Molecular Cancer Therapeutics
Issue: 5